StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Biogen (BIIB) PT Raised to $248 at Canaccord
July 30, 2026 7:20 AM
(Updated - July 30, 2026 7:51 AM EDT)
Canaccord analyst Sumant Kulkarni raised the price target on Biogen (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change